With GLP-1 supply stabilizing after a 600% surge in U.S. use between 2018–2024, the obesity treatment market is on the…
Browsing: Clinical Updates
New peer-reviewed data in Practical Laboratory Medicine confirms the analytical reliability of Geneoscopy’s scrape-free collection method used in the FDA-approved…
A JNCI decision-modeling study compared noninvasive colorectal cancer screening options using “efficient frontiers” (benefit: life-years or QALYs gained; burden: lifetime…
A new review in Nature Mental Health strengthens the case that the gut microbiome directly shapes brain chemistry, stress responses,…
OncoDaily GI spotlights the innovations transforming gastrointestinal oncology — from precision biomarkers to advances in equitable cancer care. The second…
The FDA has requested the withdrawal of obeticholic acid (Ocaliva), used to treat primary biliary cholangitis (PBC). Manufacturer Intercept Pharmaceuticals…
A new colonoscopy simulator from RZero Inc. (Mikoto™) is showing promise in training future endoscopists. Validated against the UK’s National…
A large Dutch study of over 239,000 individuals in a colorectal cancer (CRC) screening program found that endoscopist performance—measured by…
The third quarter of 2025 delivered key regulatory approvals, fresh clinical trial data, and important updates in GI care:
New research presented at DDW 2025 suggests that biomarker-guided therapy could help predict which IBD patients will respond best to…